baber/WOPTO huggingface dataset:
Patent CS-249172-B1 (CS)
Inventor: DOSTAL JIRI
IPC: F02D1/08
Filed: 1984-11-09
Abstract: Elektromagnetický akční člen je určen
pro vstřikovací čerpadla naftových motorů.
Skládá se z pevného jádra, pohyblivého
jádra, pláště, elektrické cívlty a zpětnovazebního
číslicového snímače. Jeho podstatou
je, že na pohyblivém jádru je připevněna
číslicová světelná clona, která
zasahuje do prostoru tělesa čísličového
snímače, přičemž těleso číslicového snímače
je pevně spojeno s pláštěm elektromagnetu.
Patent CS-223633-B1 (CS)
Inventor: JANSA MILOS
IPC: D03D51/34
Filed: 1981-12-07
Abstract: Účelem vynálezu je zajištění vyšší citlivosti
a spolehlivosti zařízení a následného
zastavení tkacího stroje při nepřeneseném
útku.
Uvedeného účelu se dosáhne· tím, že po
délce spodní části opěrné lišty je mezi ní
a antifrikční tkaninou elektroizolační podložka,
opatřená ve své stykové straně se zanášeči
podélnou drážkou s horním kontaktem.
Dolní kontakt je upraven v místě podélné
drážky na antifrikční tkanině, přičemž nejméně
dolní kontakt je vytvořen nánosem
elektricky vodivé vrstvy.
Předmět vynálezu lze využít ve strojírenství
a elektrotechnickém průmyslu.
Patent CS-264859-B1 (CS)
Inventor: TUMA HANUS ING CSC
IPC: G01N33/20
Filed: 1986-12-10
Abstract: Způsob stanovení množství dusíku, příp.
uhlíku vázaného na jednotlivé nitridické nebo
karbonitridické fáze vyloučené v ocelích nebo
slitinách, spočívající v tom, že se jednotlivé
fáze nejprve izolují elektrolyticky nebo
rozpouštěním kovu v kyselině. Vyloučené fáze
se pak redukují žíháním ve vodíku, přičemž se
vznikající plyny průběžně podrobují chromatografické
analýze. Zpracováním výsledků analýzy
se zjistí druh fáze, ze které se dusík nebo
uhlík uvolňují, a současně množství dusíku
nebo uhlíku ve zjištěné fázi.
Patent CS-234880-B1 (CS)
Inventor: SAFRANEK STEFAN
IPC: F15B20/00
Filed: 1983-12-22
Abstract: Predmetom vynálezu je signalizačně zariadenie
pre kontrolu stupňa zanesenia olejových
a iných tekutinových filtrov používaných
v hydraulike, mazacej technike, pri
motoroch, atď. Stupeň zanesenia signalizuje
opticky a elektricky.
Výhodou vynálezu je, že umožňuje presnejšie
riešiť termíny výměny filtračných
vložiek a olejových a tekutinových náplní,
čím ušetří značné náklady, ďalej to, že umožňuje
automaticky přepínat zanesené filtre
v takých systémoch, kde třeba zaručit
určitú čistotu, pričom reaguje iba na tlakové
poměry pri ustálenom stave systému.
Patent CS-256101-B1 (CS)
Inventor: HLAVONEK JAROSLAV
IPC: B30B15/14
Filed: 1985-12-23
Abstract: Zařízení pro řízení pohybu stroje je tvořeno snímačem spojeným se vstupním obvodem, jehož výstup je spojen jednak přes blok vyhodnocení rychlosti a převodník s prvním vstupem komparátorů a jednak s prvním vstupem bloku vyhodnocení polohy, jehož výstup je spojen s druhým vstupem komparátorů. Výstup komparátorů je spojen s prvním vstupem logické jednotky, jejíž druhý vstup je propojen s ovládacími prvky a výstup je připojen na alespoň jeden řídicí prve.k. Výstup vstupního obvodu je spojen s třetím vstupem logické jednotky. Zařízení může být doplněno indikací, která je spojena s výstupem bloku vyhodnocení rychlosti a/nebo s výstupem bloku vyhodnocení polohy a/nebo s druhým vstupem logické jednotky.
Patent DK-175616-B1 (DK)
Inventor: HAGEN FREDERICK S
IPC: C12N5/00
Filed: 1986-04-17
Granted: 2004-12-27
Abstract: DNA construct contains a nucleotide sequence (I) encoding a protein, which, on activation, has the same biological activity for blood coagulation as Factor VIIa. (I) codes at least partially for Factor VII and comprises a first sequence (Ia) encoding a calcium binding domain, joined to a second sequence downstream of (Ia), which encodes a catalytic domain for the serine protease activity of Factor VIIa. (Ia) comprises a gene encoding Factor VII, Factor IX, Factor X, Protein C, prothrombin or Protein S. - A recombinant plasmid is provided which includes a promoter followed downstream by (I), which is followed downstream by a polyadenylation signal.
Patent DK-172463-B1 (DK)
Inventor: TWARDZIK DANIEL R
IPC: C12R1/19
Filed: 1985-11-22
Granted: 1998-08-31
Abstract: Novel polypeptide compositions are provided which inhibit human tumor cell growth, which may or may not stimulate autophosphorylation of pp60 src and induce the release of a 52 kDal polypeptide from neoplastic cells. Individual polypeptides may be isolated from mammalian blood platelets by selected extraction and purification procedures, may be synthesized or produced by hybrid DNA technology.
Patent DK-167688-B1 (DK)
Inventor: HOEHN MARVIN MARTIN
IPC: C12P21/02
Filed: 1983-12-15
Granted: 1993-12-06
Abstract: There are disclosed antibiotics of formula <CHEM> wherein n is 1 or 2, or a pharmaceutically acceptable salt thereof, or an antibiotic mixture comprising an antibiotic of formula (I) or a pharmaceutically acceptable salt thereof as the major component. Antibiotic A51568 factors A and B are produced by submerged, aerobic fermentation of Nocardia orientalis NRRL 15232. The antibiotic is gram-positive.
Patent DK-175910-B1 (DK)
Inventor: TEKAMP-OLSON PATRICIA
IPC: C12N1/15
Filed: 1988-12-29
Granted: 2005-06-13
Abstract: Yeast cell comprising a DNA construct that provides for the expression and secretion of a non-yeast protein is claimed, the DNA construct comprising a coding sequence under the control of yeast-recognised transcription initiation and termination sequences, the coding sequence encoding a precursor polypeptide comprising leader sequence and the non-yeast protein linked by a processing site that provides for the cleavage of the non-yeast protein from the precursor polypeptide, where the leader sequence is 25-50 N-terminal residues of the precursor polypeptide and comprises the signal peptide of a yeast a-factor precursor and a single glycosylation site. The non-yeast protein may be a mammalian protein eg insulin-like growth factor I or a precursor of human insulin eg human proinsulin or insulin a- and insulin b-chains linked by a yeast-recognised processing site cleaved in vivo, eg a processing site cleaved by the KEX2 gene prod of Saccharomyces. Also claimed is a double-stranded DNA molecule comprising a region encoding a precursor polypeptide secretable by a yeast host, the region, with reference to one of the strands, having the structure (I) 5'-AF-CH0-Xn-S-Gene-3' (I) (AF encodes a yeast a-factor signal; CH0 encodes a glycosylation site; Xn encodes a polypeptide of n amino acids in length that does not contain a glycosylation site or a processing site that provides for cleavage of the precursor polypeptide in vivo by yeast; n is 0-30; Gene encodes a non-yeast protein; S encodes a processing site that provides for cleavage of the precursor polypeptide, eg a dipeptide eg 5'-Lys-Arg-3' or 5'-Arg-Arg-3' recognised by the KEX2 endopeptidase).
Patent FI-103245-B1 (FI)
Inventor: SIMOLA OLLI
IPC: H04W60/00
Filed: 1995-05-10
Granted: 1999-05-14
Abstract: This invention relates to a method for guidance of a mobile station user of a cellular radio system. In order to make it possible to guide the mobile station user regardless the fact, whether he himself knows his location, a service request transmitted from the mobile station is received as also the cell identification of the mobile station, which has transmitted the service request from the celllular radio system (MSC), a chart is searched based on the cell identification received to the display device (3), whereby this chart covers the geographical area, in which the mobile station is situated, and the mobile station user is guided on the grounds of the searched chart according to the service request transmitted from the mobile station. The invention is related also to a service center (1).
Patent IE-48288-B1 (IE)
Title: A clip for a surgical drainage bag
IPC: A61F/
Filed: 1979-08-08
Abstract: The colostomy bag (10), which can be emptied has an open bottom and fixture to around the stoma opening (11) also a closure to seal the open bottom part. The closure consists of two parts, the first part of which is a strip bendable in two posns. and has three clamp. The second part is a hollow sleeve enclosed but slidable in a longitudinal direction at the end of one of the clamp clamps. The two end clamps (28, 23) are arranged in such a way as to bend in a pons. parallel to the other clamps, (20) and forming a reliable seal for the bag bottom. The length of the two end clamps is approx. half the length of the intermediate clamp length.
Patent IE-39576-B1 (IE)
Title: Derivatives of 3-(p-chlorobenzoyl)-2-methyl-phenylacetic acid
IPC: C07C59/88
Filed: 1974-06-14
Abstract: Novel benzoylphenylacetic acid derivatives of the formula WHEREIN X is selected from the group consisting of geranyloxy, pivaloyloxymethoxy and, Y -N ANGLE , OZ Z is alkyl of 1 to 4 carbon atoms and Y is selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms having anti-inflammatory and analgesic activity.
[US3931286A]
Patent IE-60450-B1 (IE)
Title: Lymphokine in pure form, novel monoclonal antibodies, hybridoma cell lines, processes and applications
IPC: G01N33/53
Filed: 1985-05-23
Abstract: The invention relates to purified human macrophage migration inhibitory factor (human MIF) and its individual proteins, to a process for the purification of human MIF and for the isolation of its individual proteins, to monoclonal antibodies against human MIF, derivatives thereof, processes for the preparation of these antibodies and derivatives thereof, hybridoma cell lines which produce these antibodies, processes for the preparation of said hybridoma cell lines, and to the use of the monoclonal antibodies and derivatives thereof for the qualitative and quantitative determination of human MIF in biological fluids and on cell surfaces, and to the use of the monoclonal antibodies for the purification of human MIF. Human MIF and monoclonal antibodies against human MIF are important for the diagnosis and therapy of immunoregulatory disorders and chronic inflammatory disorders.
Patent IE-62636-B1 (IE)
Title: Arrangement for and method of administering a pharmaceutical preparation
Inventor: HSIAO CHARLES
IPC: A61K9/52
Filed: 1988-05-05
Abstract: A multitude of non-tacky coated pellets containing a pharmaceutical preparation is housed within a breakable packet which, when broken, enables ready removal of the pellets for the oral administration of the preparation to a patient. The packet includes a bendable backing sheet and a fracturable covering member between which the pellets are held in a vacuum-sealed environment prior to use. The coating of the pellets also prevents dissolution of the preparation in the mouth to avoid the sensation of bitter medicinal taste.
Patent IE-40645-B1 (IE)
Title: Visual method for the detection of syphilis and other treponemal diseases, and an antigen preparation useful therein
IPC: C09B35/04
Filed: 1974-08-07
Abstract: An antigen preparation for use in the detection of syphilis and other treponemal diseases comprising (1) V.D.R.L. or U.S.R., antigen reagent and (2) A. A COMPOUND HAVING THE FORMULA B. A COMPOUND HAVING THE FORMULA C. A COMPOUND HAVING THE FORMULA OR (D) MIXTURES OF (A) + (B) OR (A) + (C), AND (3) WHICH MAY ADDITIONALLY INCLUDE A POLYMERIC FLOCCULATING AGENT. A method of using said antigen preparation and a test card having a flocculating agent deposited thereon, are also disclosed.
[US3949065A]
Patent IE-39844-B1 (IE)
Title: Improvements in and relating to inflatable buoyant devices
IPC: B23C/
Filed: 1974-09-12
Abstract: An inflatable bouyancy aid comprises an elongate, straight inflatable member, and a securing device attached to and extending from the inflatable member and adapted to encircle the trunk part of the body of a wearer. An actuating device is associated with a gas producing device located in or adjacent the inflatable member such that on operation of the actuating device an amount of gas flows into the inflatable member so as to inflate it and provide buoyancy for the wearer. The securing device extends from two positions spaced apart and removed from each end of the inflatable member to leave two end portions of the inflatable member, when inflated, extending in substantial tangential fashion from the body of the wearer.
[US3952355A]
Patent IE-39946-B1 (IE)
Title: Methods and apparatus for treating waste water
IPC: C02F1/52
Filed: 1974-10-15
Abstract: 1495755 Purifying waste water TELECOMMUNICATIONS INDUSTRIES Inc 4 Dec 1974 [7 Jan 1974] 52468/74 Heading C1C [Also in Division B1] Waste water is purified in an apparatus comprising an equalization tank, a settling tank, a weir in the settling tank, means for transferring waste water from the equalization tank to the weir, means for introducing a coagulating agent to the settling tank, a flocculation tank, a submerged weir extending between the settling tank and the flocculation tank for permitting flow of waste water from the settling tank to the flocculation tank, means for adding polyelectrolyte to the waste water in the vicinity of the submerged weir, means for slowly stirring the waste water in the flocculation tank, a clarification tank, a second submerged weir for permitting the passage of waste water from the flocculation tank to the clarification tank, the clarification tank having an outlet therein, a lamellar device disposed within the clarification tank between the second submerged weir and the outlet for removing suspended solids from the waste water, a vertically extending ozonationsonication tower having an inlet adjacent its upper end and an outlet adjacent its bottom, means for transferring waste water from the outlet of the clarification tank to the inlet for the tower, means for introducing ozone into the tower, means below the tower inlet and above the means for introducing ozone into the tower for imparting sonic energy to the tower at a power level sufficient to cause cavitation in water within the tower.
[GB1495755A]
Patent IE-43637-B1 (IE)
Title: Phenoxyalkylcarboxylic acid derivatives
IPC: C07C51/00
Filed: 1976-10-20
Abstract: 1502236 Phenoxyalkylcarboxylic acids BOEHRINGER MANNHEIM GmbH 15 Oct 1976 [21 Oct 1975] 42900/76 Heading C2C Novel compounds I [in which B is a bond or C 1-3 hydrocarbyl, n is 1 or 2 and R 1 , R 2 and R 3 are H or C 1-6 alkyl] and salts where R 3 is H; are prepared by condensing p - amino - C 1-2 alkyl - phenol or a derivative thereof with an acid III or a derivative thereof and with X-CR 1 R 2 -Y in which X is a radical derived from an anion of a strong acid and Y is COOR 3 or a CN, CHO or CH 2 OH group which is converted after condensation to a COOR 3 group and optionally esterifying or salifying a free acid obtained. Compounds I lower serum lipid and cholesterol levels and have a thrombocyte aggregation inhibiting action. They form with a diluent or carrier a pharmaceutical composition which may be administered orally or parenterally.
Patent IE-51916-B1 (IE)
Title: Improvements in and relating to ear tags
IPC: A01K11/00
Filed: 1981-10-15
Abstract: A one piece identification tag which is formed from a flexible material. The tag comprises a panel 10 on which identification indicia can be applied. A neck portion 11 extends from the panel 10 and terminates in a head portion 12. The head portion 12 has a pair of flaps 14 which project backwardly therefrom toward the panel 10 with a flap 14 being situated either side of the neck portion 11.
Patent IE-62103-B1 (IE)
Title: The use of 2',3'-Dideoxycytidin-2'-ENE (2',3'-Did eoxy-2',3'-Didehydrocytidine) in treating Patientsinfected with Retroviruses
Inventor: LIN TAI-SHUN
IPC: C07D405/04
Filed: 1987-09-23
Abstract: The invention relates to a pharmaceutical composition for treating warm blooded animals infected with a retrovirus, comprising an anti-retroviral effective amount of 2', 3'-dideoxycytidin-2'-ene or a pharmaceutical acceptable salt thereof, either alone or in admixture with usual additives.
Patent IE-69563-B1 (IE)
Title: Method for preparing a transparent adjusted milk whey protein and an adjusted milk whey protein product
Inventor: KITABATAKE NAOFUMI
IPC: A23J1/20
Filed: 1991-07-29
Abstract: A transparent adjusted milk whey protein is prepared by a method in which milk whey protein is purified and then the pH of a solution containing the milk whey protein is adjusted to not higher than 4 or not lower than 6. The solution may be heated to a temperature not lower than 55  DEG C before or after adjusting the pH. Further, an adjusted milk whey product is prepared by a method in which the pH of a solution containing milk whey protein is adjusted to not higher than 4 or not lower than 6 and the solution is heated at a temperature not lower than 55 DEG C and cooled to a temperature not higher than 10  DEG C, or a method in which the pH of a solution containing purified milk whey protein is adjusted to not higher than 4 or not lower than 6 under such a condition as salt content of the solution is 0 or not higher than 50 mM, and the solution is heated at a temperature not lower than 55 DEG C and cooled to a temperature not higher than 10  DEG C.
Patent IE-62008-B1 (IE)
Title: "Solid phase peptide synthesis"
Inventor: CALAS BERNARD
IPC: C07K1/10
Filed: 1989-09-22
Abstract: Solid phase peptide synthesis is accomplished on polyacrylic resins by a method which includes, in the coupling protocol, steps of washing the resin in water and/or aqueous solutions.
Patent IE-74225-B1 (IE)
Title: Delayed release oral dosage forms for treatment of intestinal disorders
Inventor: RHODES JOHN
IPC: A61K33/24
Filed: 1992-02-21
Abstract: PCT No. PCT/GB92/00318 Sec. 371 Date Aug. 20, 1993 Sec. 102(e) Date Aug. 20, 1993 PCT Filed Feb. 21, 1992 PCT Pub. No. WO92/14452 PCT Pub. Date Sep. 3, 1992.An orally administrable pharmaceutical dosage form for selectively administering a drug to the intestine comprises a plurality of enteric coated granules of the drug contained in an enterically coated capsule which releases the granules in the small intestine. The granules are preferably coated with a coating which remains intact until the coated granules reach at least the ileum and thereafter provide a sustained release of the drug in the colon. Suitable coating materials are selected from the Eudragit range of (meth)acrylate and (meth)acrylic and polymers. The invention has particular application to topically active drugs such as topically active steroids, bismuth salts and complexes, and especially, 5-amino-salicylic acid.
Patent IE-80648-B1 (IE)
Title: Controllably affecting fertilizer composition
Inventor: AHLNAS TOMAS
IPC: C05G3/50
Filed: 1992-07-01
Abstract: A fertilizer controllably affecting composition which is easy to handle and which has enormous ability to transfer nitrogen to plant organism and improve to growth, has now been invented by including into it 30-90 % by weight of a compound containing plant nutrients, 6-50 % by weight of water, 2-20 % by weight of oil and 2-25 % by weight of water-in-oil type (w/o) surfactant, whereby the composition is in the form of a stable paste or an emulsion slurry.
Patent LU-101671-B1 (LU)
Title: Porous Sn-C3N4 nanosheet and preparation thereof
Inventor: XU HAIFENG
IPC: B01J27/24
Filed: 2020-03-09
Granted: 2020-07-09
Abstract: The present disclosure provides a method for preparing a porous Sn-C3N4 nanosheet, including the following steps: mixing a tin source compound with a carbon and nitrogen source compound to obtain a mixed compound, pulverizing the mixed compound, and sieving the mixed compound through a mesh sieve; calcining the sieved material at 500-570°C; grinding and pulverizing the calcined product to obtain porous Sn-C3N4 nanosheet powder. The prepared porous Sn-C3N4 nanosheet can effectively utilize the sunlight, provides a short diffusion distance for charge transfer, and has a good photoelectrochemical and photocatalytic activity under a visible light, which has a wide application prospect in the field of solar energy conversion.
Patent LU-101857-B1 (LU)
Title: Ankle joint rehabilitation training device and operation method for promoting blood circulation
Inventor: ZHAO YA
IPC: A63B23/08
Filed: 2018-12-27
Granted: 2020-12-04
Abstract: The invention discloses an ankle joint rehabilitation training device and an operation method for promoting blood circulation, which includes two pedals, an extension plate is provided on one side of each pedal, a positioning plate is provided on the other side of each pedal, and an extension plate is provided on the extension plate The outer side is provided with a limit plate, and each of the extension plates is provided with two first sliding grooves, and an adjusting plate is slidingly connected between the two first sliding grooves, and the adjusting plate and the limiting plate are connected by a return spring. Each pedal is provided with a pull plate that can adjust the length of the pedal. There are evenly distributed heating bumps containing heating wires on the front of the pedal.
Patent LU-102485-B1 (LU)
Title: Method for rapid extraction and analysis of 10 polycyclic aromatic hydrocarbons in water
Inventor: CHEN YALI
IPC: G01N30/06
Filed: 2020-04-14
Granted: 2021-03-12
Abstract: The disclosure relates to a method for rapid extraction and analysis of 10 polycyclic aromatic hydrocarbons in water. A parallel solid-phase membrane sheet sample pretreatment microplate system device involved in this method is composed of an oscillating device, a sample container and a membrane sheet system. An ultra-high performance liquid chromatography-triple quadrupole rod mass spectrometry is used to quantitatively determine the content of environmental pollutant polycyclic aromatic hydrocarbons, wherein the detection is completed within 10 min, and the average pretreatment time of each sample is about 1 min. This method is good in reproducibility and stability, and is a rapid and effective means to extract and determine the content of polycyclic aromatic hydrocarbons in water.
Patent LU-500951-B1 (LU)
Title: Composition with tyrosinase inhibiting effect and its application
Inventor: WANG YAN
IPC: A61K31/05
Filed: 2021-12-03
Granted: 2022-06-03
Abstract: This invention provides composition with tyrosinase inhibiting effect and its application, which consists of glabridin and resveratrol in a mass ratio of 0.33-3. Experiments prove that the composition provided by the invention has the effect of synergistically inhibiting tyrosinase, which can be used for treating chloasma, acne healing, freckle, senile plaque, post-sun repair and antioxidation.